Coherus Biosciences | Profitto Lordo Sulle Vendite

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Profitto Lordo Sulle Vendite Cambiamento Data
AbbVie USD 10.47B 605M 2025-09
Acadia Pharmaceuticals USD 256.99M 13.15M 2025-09
Akebia Therapeutics USD 49.21M 13.25M 2025-03
ALKERMES USD 265.83M 8.06M 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amarin USD 22.21M 28.15M 2025-09
Amgen USD 6.48B 307M 2025-09
Baxter International USD 950M 194M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 4.95M 15.34M 2025-03
Eli Lilly USD 14.59B 1.48B 2025-09
Fujifilm JPY 347.51B 14.74B 2025-12
Gilead Sciences USD 6.2B 620M 2025-09
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Merck USD 13.42B 431M 2025-09
Myriad Genetics USD 143.8M 8M 2025-09
Pacira USD 130.92M 5M 2025-09
Perrigo USD 377.1M 14.2M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 187.69M 24.3M 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
Vertex Pharmaceuticals USD 2.66B 104.4M 2025-09
Xencor USD 21M 22.61M 2025-09
Zoetis USD 1.72B 96M 2025-09


Coherus Biosciences Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.